HOW THE SYMPOSIUM IS UNIQUE This Symposium features the presentation - PDF document

INSTITUTE OF INTELLECTUAL PROPERTY II P RD RESEARCH AND DEVELOPMENT & SUGHRUE MION, PLLC, OF THE U S A SUGHRUE Presents THREE – DAYS INTERNATIONAL SYMPOSIUM ON STRATEGIES FOR MANAGING PHARMA/BIOTECH/CHEMICAL PATENT PORTFOLIO With Focus on: UNITED STATES, EUROPE & CHINA SCENARIO AT From: Hotel 2nd - 4th Le Royal September Meridian, 2009 Mumbai With Support of : K K & & KHURANA & KHURANA, ADVOCATES & IP ATTORNEYS

ABOUT THE SYMPOSIUM In a business environment where competition in Pharma, Biotech and Chemical Industry is becoming increasingly aggressive, there is an urgent need to understand the competitive leverage that an efficient Intellectual Property Portfolio can provide. An understanding of International Patent Laws and Practices for regulating and protecting one's business, world over, becomes critical for the business growth and there is therefore an urgent need to understand important issues relating to strategies for generic pharmaceutical manufacturers, identification of invention, types of applicable claims, formulation of set of claims, drafting issues, claim drafting, review of recent case laws impacting claim drafting, amendments during prosecution, how to effectively understand and respond to communications from EPO and USPTO examiners for avoiding prosecution, litigation strategies, impact of major decisions on litigation strategies to extend product life when a drug comes off patent. At the same time Patent Laws & Practices differ substantially between Nations, in terms of their Grant, Scope, Protection and Enforcement mechanisms and therefore need to be well understood and this symposium is organized only in this direction. The symposium will also focus substantially on strategies for generic pharmaceutical manufacturers who seek to enter the U.S. market, obviousness issues relating to active pharmaceutical ingredients, evolving trends in declaratory judgment actions, unique aspects of Orange book listing strategies, litigating ANDA and strategic use of ANDA's infringement, patent trolls and patent portfolio structure for Pharma, Biotech and Chemical Industry. HOW THE SYMPOSIUM IS UNIQUE This Symposium features the presentation of all important patent issues covering Pharma Biotech and Chemicals products and processes. Composition of the panelists is a unique gathering of Patent Attorneys and Litigators from USA, Europe, China and India who have extensive years of experience in their professional fields and will put across to the delegates the real insight of Patent Laws and Practices and first-hand information through well coordinated and structured modules. This is a one time opportunity when Seven Patent/ Litigation Experts would be interacting with limited delegates and would answer to any question that the delegates may have. Symposium would also provide to its participants an exclusive opportunity to interact and discuss personal patent issues with speakers, even on one to one basis and if required in confidentiality. Composition of the team and the coverage is so selected that R&D Scientists, Patent Attorneys, and Legal Corporate team at Pharma, Biotech and Chemical Industry will get to know the real insight and nitty gritty followed at USPTO, Europe and China Patent Office. The knowledge gained from the workshop will go a long way in formulating the right patent strategy and managing Patent Portfolio. WHO SHOULD ATTEND Research & Development Scientists, IP Managers, Patent Agents & Attorneys in the field of Practice, Patent Litigators and Managers in Generic Drugs Companies, Professionals in Legal Domain related to Pharma, Biotech and Chemicals.

ABOUT THE FACULTY Mr. Kenneth J. Burchfiel: Burchfiel is a senior partner with Sughrue Mion. Burchfiel has expertise of 30 years in patent domain with focuses on Pharma, General Organic Chemistry and Biotechnology. Burchfiel was the first American patent lawyer admitted to practice in Japan under the reciprocal foreign law practice statute. His practice includes litigation before the federal courts, interferences and appeals. He also testifies as an expert witness on patent law and US PTO practice and procedure. In addition to his litigation and interference practice, Burchfiel counsels a variety of international and domestic clients regarding U.S. intellectual property law including providing clearance, enforceability, and validity opinions. Burchfiel has numerous publications and teaching and has spoken on various international symposium. He is also a visiting Scholar to Max-Planck among other universities/ Institutes. Mr. Chid Iyer: Chid received a B. Tech in Chemical Engineering from IIT, Bombay in 1984, an MS in Chemical Engineering from University of Akron and an MS in Computer Science from the University of Tennessee Space Institute. He received his JD from Georgetown University in 1997. Chid is a partner of International Law Firm of Sughrue Mion and is involved in all aspects of patent practice including litigation, prosecution and client counseling in a variety of technologies with focus on chemical and pharmaceutical. Chid has prepared and prosecuted over fifty applications for a leading research laboratory. Chid has conducted and presented in various workshops and seminars on patent practice at various locations in U.S, Korea, Japan, and India. He is currently chairing the AIPLA subcommittee on IP practice in India. Mr. Michael R. Dzwonczyk: Michael has over 15 years experience successfully representing multinational companies in patent litigation, including trials and appeals of patent cases. His experience has encompassed technical areas that include pharmaceuticals, recombinantly produced hormones, protein synthesis and expression products, fibers, and medical devices. His interference practice has included topics in chemistry and biotechnology including hormone and gene therapeutics, as well as anticholesterics. Michael also counsels clients on intellectual property issues, including validity and infringement of intellectual property rights, licensing and contract matters and Hatch-Waxman issues. He has lectured on numerous topics including strategies for drafting pre-litigation opinions, pharmaceutical litigation strategies, and Patent Law Reform. Dr. William Simmons: Simmons is an associate at Sughrue Mion and works out of the Washington office. He did his masters in Biological Sciences in 1995. Simmons practice focuses on worldwide procurement, defense and enforcement of patents in the biotechnology and chemical industries. Simmons works in all areas of patent law, including interferences, reexaminations, oppositions and prosecution. Simmons prepares opinions regarding patentability and infringement and conducts freedom-to-operate analysis. He did his Post-doctoral Fellow from National Institute of Health at New York University.